ReNu Recall News

Bausch & Lomb has settled 600 ReNu lawsuits for $250M

June 1st, 2009

Over the last year, Bausch & Lomb, the manufacturer of ReNu with MoistureLoc contact lens solution, has paid more than $250 million to settle nearly 600 lawsuits filed by users of the product who developed fungal eye infections, according to a report by the Associated Press. The lawsuits allege that contact lens solution caused them to develop fungal eye infections, including a potentially blinding infection known as Fusarium keratitis. More »

FDA panel calls for tougher contact lens warnings

June 10th, 2008

A Food and Drug Administration panel of eye experts has backed a series of stronger warnings designed to prevent eye infections among contact lens wearers. The proposed warnings came about as a result of two high profile infection outbreaks that occurred in 2006 and 2007.

More »

Hissey Kientz, LLP Files Lawsuit Against ReNu with MoistureLoc Maker

May 26th, 2007

The law office of Hissey Kientz announced this week that it has filed a lawsuit against Bausch & Lomb on behalf of a 16-year-old girl who suffered corneal scarring due to a severe eye infection (Case No. 2:07-CV-00954). The lawsuit alleges that the victim’s use of Bausch & Lomb’s ReNu with MoistureLoc contact lens solution caused her to develop a severe eye infection (keratitis), leading to permanent corneal scarring and eye damage. More »

Two NY women file ReNu lawsuit

December 18th, 2006

Two women who developed eye infections after using the contact lens solution ReNu with MoistureLoc have filed a lawsuit against its manufacturer, Bausch & Lomb. Melissa Ippolito and Yomaira Santiago—both of Staten Island, New York—allege in their ReNu lawsuit that using the contact lens solution caused them to develop symptoms of Fusarium keratitis. As a result of their infections, both women lost some vision in one eye.

More »

First ReNu lawsuits set to begin next week in SC

December 14th, 2006

Proceedings in the first round of ReNu lawsuits against Bausch & Lomb are scheduled to begin next week in South Carolina. Lawyers from Bausch & Lomb will meet with ReNu attorneys and their clients from 80 cases to exchange information. After a judge oversees the exchange of documents and information, the cases will be returned to their original location for trial. Most of the ReNu lawsuits that have been filed so far are scheduled to go to trial between a year and 18 months from now.

More »

Bausch & Lomb may be facing 1,000 ReNu lawsuits

December 14th, 2006

Although the first of many ReNu lawsuits are only beginning to make their way to court, legal experts predict that many more could be on the way in the near future. Estimates by some ReNu attorneys say that up to 1,000 ReNu lawsuits could eventually be filed.

More »

FDA warning letter cites Bausch & Lomb for violations

November 7th, 2006

Bausch & Lomb says that it is more than two-thirds of the way to correcting all of the regulatory violations at its Greenville, South Carolina plant that were cited by the Food and Drug Administration in an October letter to the company. It says, however, that the agency’s concern will not be met until the FDA has the chance to review the corrections.

More »

FDA letter faults Bausch & Lomb for delays in ReNu recall

November 6th, 2006

Officials with the Food and Drug Administration have criticized Bausch & Lomb for its failure to quickly report almost three dozen eye infections linked to its ReNu with MoistureLoc contact lens solution.

More »

ReNu with MoistureLoc still getting 2% of market

October 23rd, 2006

Despite being recalled by Bausch & Lomb in April, the contact lens solution ReNu with MoistureLoc retained a 2% market share in early September, according to AC Nielsen market data. Use of the solution has been linked to a
serious fungal eye condition known as Fusarium keratitis, but this information raises doubts as to just how diligent and aggressive the
company has been in alerting patients, retailers
and physicians to ReNu’s potential dangers and side effects.

More »

Bausch & Lomb in short-term financial trouble after ReNu recall

September 27th, 2006

A financial analyst with the Prudential Equity Group is predicting a bleak short-term financial future for Bausch & Lomb. Larry Biegelsen says that new competition in the contact lens market, a lack of new products and financial troubles will halt the company’s growth for 12 to 18 months.

More »

Page 1 of 41234
I am currently represented by an attorney
*Required fields